
欧洲医学成像市场预测至 2028 年 - COVID-19 影响和按产品进行区域分析(CT 系统、X 射线系统、PET 系统、MRI 系统、超声系统等);最终用户(医院、手术中心、临床医生办公室和紧急护理中心)
No. of Pages: 152 | Report Code: TIPRE00025111 | Category: Life Sciences
No. of Pages: 152 | Report Code: TIPRE00025111 | Category: Life Sciences
医学成像是指为诊断和治疗目的而创建人体各部位图像的技术和过程。数字健康。术语“医学成像”包括各种放射成像技术,例如:X 射线照相、透视、磁共振成像 (MRI)、医学超声检查或超声波、内窥镜检查、弹性成像、触觉成像、热成像、医学摄影和核医学功能成像技术例如,正电子发射断层扫描(PET)。医学成像在每个医疗环境和各级医疗保健中都至关重要。
因此,对早期诊断的需求不断增加,预计将在未来几年对医学成像产生巨大的需求,进一步预计这将在未来几年内产生巨大的需求。推动医学成像市场。
由于医疗人员的多样化以及专注于治疗危重疾病的决定,COVID-19 的增加影响了疾病的诊断和治疗。由于当前的大流行,许多从事超声波换能器治疗的癌症研究组织没有预约,以避免与之相关的焦虑。由于新的临床实践,乳腺肿瘤学家正在优先考虑患者,并通过提供更少的治疗来做出艰难的选择。胸部的特异性和敏感性主要是通过 COVID-19 阳性患者的计算机断层扫描来确定的。 COVID-19 大流行的规模导致需要获取大量成像数据。传统上,使用影像数据的研究最多构成单个医院或医院集团内的数据整理。因此,欧洲各国 COVID-19 患者进行的医学成像量可能会对市场的增长产生积极影响。
欧洲医学成像市场预计将比美国增长2021 年为 77.039 亿美元,到 2028 年为 100.031 亿美元;预计 2021 年至 2028 年复合年增长率为 3.8%。在诊断放射学中使用 3D(甚至可能是 4D)技术可以创建更好的图像,从而获得强大的结果。尽管超声波在医学领域非常流行,但由于无法获得高分辨率、详细的图像而受到限制。使用 3D 技术可以提高超声分辨率并增强患者护理。 CareStream Health 是数字医疗解决方案和医疗保健 IT 基础设施领域的领导者,其专家也一直在探索成像领域的 3D 功能,特别是 CT 扫描领域。与传统 CT 图像相比,OnSight 3D Extremity System 中的软件增加了软组织的对比度,并降低了金属伪影的可见度。这些改进可实现清晰的 3D 构建,并有助于更好地了解患者健康状况。
从产品角度来看,X射线系统领域在2020年欧洲医学影像市场中占据最大份额。从最终用户角度来看,医院领域在欧洲医学影像市场中占据最大份额2020年市场。
准备本欧洲医学成像市场报告时参考的一些主要一手和二手来源包括公司网站、年度报告、财务报告、国家政府文件和统计数据库等。报告中列出的主要公司包括通用电气公司、西门子股份公司、荷兰皇家飞利浦公司、岛津制作所、日立有限公司、佳能公司、Hologic, Inc.、Carestream Health Inc.、ESAOTE SPA 和三星集团。
按产品
由最终用户
按国家/地区
Strategic insights for Europe Medical Imaging involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 7,703.9 Million |
Market Size by 2028 | US$ 10,003.1 Million |
Global CAGR (2021 - 2028) | 3.8% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By 产品
|
Regions and Countries Covered | 欧洲
|
Market leaders and key company profiles |
The regional scope of Europe Medical Imaging refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Europe Medical Imaging Market is valued at US$ 7,703.9 Million in 2021, it is projected to reach US$ 10,003.1 Million by 2028.
As per our report Europe Medical Imaging Market, the market size is valued at US$ 7,703.9 Million in 2021, projecting it to reach US$ 10,003.1 Million by 2028. This translates to a CAGR of approximately 3.8% during the forecast period.
The Europe Medical Imaging Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Medical Imaging Market report:
The Europe Medical Imaging Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Medical Imaging Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Medical Imaging Market value chain can benefit from the information contained in a comprehensive market report.